1. Valuing Medical Technologies: An Alberta Perspective Don Juzwishin PhD. Director Health Technology Assessment and Innovation April 13, 2015

2. 2 The Context Transformation Structural changes Process challenges Fiscal challenges Implementation Relevance Timeliness Opportunity for refinement

3. 3 The Approach Collaborative Partnership of AH, AIHS & AHS Review and refine AACHT Formation of SCNs Focus on unmet needs Facilitate technology pull Identify disinvestment Collaboration with IHE, U of A, U of C, CADTH Top down meets bottom up Research + Innovation Users of Knowledge On the same team New Knowledge with value

4. 4 1.Diabetes, Obesity and Nutrition - SCN 2.Seniors’ Health - SCN 3.Bone & Joint Health - SCN 4.Cardiovascular and Stroke - SCN 5.Cancer - SCN 6.Addiction & Mental Health - SCN 7.Emergency - SCN 8.Critical Care - SCN 9.Surgery – SCN 10.Respiratory - SCN 11. Primary Care & Chronic Disease 12.Maternal, Child, Newborn & Youth Health 13.Kidney 14.Diagnostics (Imaging/Lab Medicine) 15.Gastrointestinal 16.Neuroscience, Vision, ENT 2012 - 2014 (others under consideration) Strategic Clinical Networks (SCNs) – each has SD

5. 5 Opportunities ICER and DCF become confluent and below the WTP threshold Request for innovation Stimulate commercialization Replenish research feedstock